Press Release

CD BIOPARTICLES LAUNCHES AFFINITY CHROMATOGRAPHY RESINS FOR LABORATORY USAGE



CD Bioparticles has launched a range of Affinity Chromatography Resins for research applications.

FOR IMMEDIATE RELEASE

19/05/2023

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has launched a range of 10-100 μm diameter Affinity Chromatography Resins to meet customer needs for biopharmaceuticals, natural products and downstream purification of biologics using polymethyl methacrylate (PMMA) and agarose.

These affinity chromatography resins utilize world-leading microspheres as a matrix with precise material composition, particle size, particle size uniformity, pore size and surface properties. In addition, the monodisperse microspheres exhibit consistent diameter, pore channel, surface properties and chromatographic peak shape, showing good chemical stability at low counterpressures and more dynamic adsorption load even at high flow rates.

Currently, affinity chromatography media on the market are divided into two major categories, i.e., polysaccharide-based (agarose, dextran, cellulose) and synthetic polymer-based (polyacrylate, acrylamide). For this new portfolio, CD Bioparticles offers microspheres with two materials, PMMA and agarose, to meet customers' needs in laboratory preparation, pilot testing and industrial production.

Porous PMMA affinity chromatography particles contain a rigid monodisperse porous PMMA microsphere as a core, which ensures better mechanical properties of the medium, is more pressure resistant and supports a higher and more stable column bed. Moreover, the polyhydroxyl structure of dextran provides good hydrophilicity and reduced non-specific adsorption, while the polyhydroxyl group allows more Protein A binding sites for higher loading capacity and improved antibody batches. Meanwhile, agarose affinity chromatography particles possess a reticulated structure in the dissolved state with a large specific surface area and relatively high affinity loading.

Applications

In vitro antigen-antibody reactions.
Enzyme assays, substrate detection, and enzyme binding site studies.
Detection of single nucleotide polymorphisms and mutations in nucleic acids.
Separation of compound mixtures, and removal of impurities.
Isolation and purification of nucleic acids and proteins from cell extracts.

CD Bioparticles provides various functional ligands, including N(CH2COOH)2, N(CH2COOH)3, Ni2+, Phenylboronic acid, Protein A, and rProtein A. For example, DiagNano™ rProtein A Porous Agarose Particles (90 μm) are monodisperse porous agarose particles with terminal rProtein A groups on their surface. They are widely used in continuous flow purification of antibodies because of their high mechanical strength, good compression resistance, stable column bed and fast mass transfer.

Another example is DiagNano™ rProtein A Porous PMMA Particles, High Capacity, 50 μm. They have demonstrated high mechanical strength, low back pressure, good chemical stability and high alkali resistance with higher capacity than PPD-71, making them suitable for the isolation and purification of monoclonal antibodies and recombinant protein biomolecules containing Fc (functional chromatography) fragments.

For more information about affinity chromatography resins or to discuss your projects, please visit CD Bioparticles at https://www.cd-bioparticles.com/.

About CD Bioparticles

CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.

Tags:
CD Bioparticles  |  Affinity Chromatography Resins  |  

---

Organisation Profile:
CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.






Press release contact details for CD Bioparticles

NameCD Bioparticles
Tel1-631-346-0027
Fax
Email
Websitehttps://www.cd-bioparticles.net/
OrganisationCD Bioparticles
Address
Town
County0
Postcode




Other press releases from CD Bioparticles

CD Bioparticles Launches Gene Silencing for Bio-research Application
CD Bioparticles Launches Gel Permeation Chromatography Resins
CD Bioparticles Introduces Reversed Phase Chromatography Resins for Biological Analysis
CD Bioparticles Launches mRNA Transfection Reagents for Research Applications
CD Bioparticles Launches Normal Phase Chromatography Resins for Chromatographic Analysis
CD Bioparticles Launches 3D Transfection Reagents for Bio-research Applications
CD Bioparticles Launches Affinity Chromatography Resins for Laboratory Usage
CD Bioparticles Announces Carrageenans for Scientific Applications
CD Bioparticles Launches New Chromatography Resins for Improved Analysis and Preparation of Chiral Compounds
CD Bioparticles Launches New Alginic Acids for Research Applications
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles Announces New PLGA-Based Drug Delivery Systems for In Vitro and In Vivo Applications
CD Bioparticles Launches New Line of Bioinks for 3D Bioprinting
CD Bioparticles Launches New Quantum Dots Labeling & Conjugation Kits
CD Bioparticles Introduces New Extraction and Purification Kits for Rapid and Reliable DNA Isolation
CD Bioparticles Launches New Tissue Engineering Scaffolds for Researchers
CD Bioparticles Launches New Line of Polystyrene Particles Conjugated with Biomolecules
CD Bioparticles Launches 3D Cell Culture Substrate for Bio-research
CD Bioparticles Announces the Launch of New Flow Cytometry Particles
CD Bioparticles Introduces the Launch of Engineered Tissue Scaffolds
CD Bioparticles Announces Polyamino Acids for Drug Delivery Applications
CD Bioparticles Launches New Line of Functional Polystyrene Particles
CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research
CD Bioparticles Unveils Versatile Plain Polystyrene Particles for Diverse Bioresearch Applications
CD Bioparticles Launches New Range of Low PDI Polymers for Drug Delivery Applications
CD Bioparticles Launches New Line of Particles for Solid Phase Organic Synthesis
CD Bioparticles Introduces Innovative Agarose Particles for Purification of Proteins and Antibodies
CD Bioparticles Announces New Line of Polyacrylamides for Drug Delivery Studies
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomolecule Separation
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Applications
CD Bioparticles Announces New Line of Conjugated Agarose Particles for Affinity Separation and Purification
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Delivery
CD Bioparticles Announces Comprehensive Assay Portfolio for mRNA-LNP Vaccine Development
CD Bioparticles Introduces Functional Agarose Particles for Biomedical Research Applications
CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles
Endotoxin Free Gold Nanoparticles for Biomedical Research and Bioassay Development
CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.